Newborn screening: the role of the obstetrician.
Larsson
Agne
A
Karolinska Institute, Huddinge University Hospital, Sweden. Agne.larsson@klinvet.ki.se
Therrell
Bradford L
BL
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis / Q000517:prevention & control; D028921:Biotinidase Deficiency / Q000175:diagnosis / Q000517:prevention & control; D003409:Congenital Hypothyroidism; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000517:prevention & control; D005693:Galactosemias / Q000175:diagnosis / Q000517:prevention & control; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000175:diagnosis / Q000517:prevention & control; D006450:Hemoglobin SC Disease / Q000175:diagnosis; D006712:Homocystinuria / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis / Q000517:prevention & control; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis / Q000517:prevention & control*; D008375:Maple Syrup Urine Disease / Q000175:diagnosis / Q000517:prevention & control; D008661:Metabolism, Inborn Errors / Q000175:diagnosis / Q000517:prevention & control; D015997:Neonatal Screening / Q000379:methods; D009774:Obstetrics; D010661:Phenylketonurias / Q000175:diagnosis / Q000517:prevention & control; D010819:Physician's Role